2 High-Yield Dividend Stocks to Buy Right Now

Core Insights - High-yield dividend stocks are expected to benefit from potential interest rate cuts by the Federal Reserve due to signs of cooling in the U.S. labor market, economy, and core inflation [1] - AbbVie and Pfizer are highlighted as attractive high-yield dividend stocks with strong yields and favorable valuations [1] AbbVie - AbbVie offers a dividend yield of 3.87% and has increased its dividend by 10% annually over the past five years, outperforming the average 6% increase among top dividend growers [2] - The company's shares trade at under 15 times forward earnings, significantly lower than the S&P 500's nearly 21 times forward earnings [2] - AbbVie is managing the loss of market exclusivity for its key drug Humira effectively, with strong sales from newer immunology medications Skyrizi and Rinvoq, and positive performance from the neuroscience drug Vraylar [3] Pfizer - Pfizer has a dividend yield of 5.87% and is trading at less than 13 times future earnings, positioning it for long-term outperformance [4] - The company has faced revenue declines due to reduced sales of COVID-19 products and a lack of investor interest in its acquisitions [4] - Pfizer is shifting focus towards oncology, which is expected to provide strong pricing power and competitive advantages, making it a top pick for dividend investors [5]